Technical Analysis for VRML - Vermillion, Inc.

Grade Last Price % Change Price Change
grade C 1.14 0.88% 0.01
VRML closed up 0.88 percent on Friday, May 24, 2019, on 15 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical VRML trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze Ended Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction 0.88%
Lower Bollinger Band Walk Weakness 0.88%
Stochastic Reached Oversold Weakness 0.88%
BB Squeeze + Lower Band Touch Range Contraction 0.88%
Below Lower BB Weakness 0.88%

Older signals for VRML ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Vermillion, Inc., together with its subsidiaries, engages in the discovery, development, and commercialization of diagnostic tests that help physicians diagnose, treat, and enhance outcomes for patients. The company develops diagnostic tests in the fields of oncology, cardiology, and women's health. Its lead product is OVA1, an ovarian cancer blood test for pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. The company is also involved in developing various programs in other clinical aspects of ovarian cancer, as well as in peripheral arterial disease. Vermillion, Inc. has strategic alliance agreement with Quest Diagnostics Incorporated to develop and commercialize diagnostic tests. It serves clinical reference laboratories, hospital laboratories, and physician offices. The company was formerly known as Ciphergen Biosystems, Inc. and changed its name to Vermillion, Inc. in August 2007. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.
Medicine Health Medical Specialties Oncology New Jersey Ovarian Cancer Diagnostic Tests Corning Inc. Peripheral Arterial Disease Gynaecological Cancer Quest Diagnostics
Is VRML a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 1.57
52 Week Low 0.1
Average Volume 113,395
200-Day Moving Average 0.7694
50-Day Moving Average 1.2461
20-Day Moving Average 1.2484
10-Day Moving Average 1.2279
Average True Range 0.095
ADX 19.93
+DI 14.4686
-DI 22.2415
Chandelier Exit (Long, 3 ATRs ) 1.0983
Chandelier Exit (Short, 3 ATRs ) 1.385
Upper Bollinger Band 1.3577
Lower Bollinger Band 1.1391
Percent B (%b) 0.0
BandWidth 17.510413
MACD Line -0.0159
MACD Signal Line 0.0053
MACD Histogram -0.0212
Fundamentals Value
Market Cap 64.02 Million
Num Shares 56.2 Million
EPS -0.22
Price-to-Earnings (P/E) Ratio -5.18
Price-to-Sales 25.03
Price-to-Book 16.79
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.25
Resistance 3 (R3) 1.25 1.21 1.23
Resistance 2 (R2) 1.21 1.19 1.21 1.22
Resistance 1 (R1) 1.18 1.17 1.16 1.18 1.22
Pivot Point 1.14 1.14 1.14 1.14 1.14
Support 1 (S1) 1.11 1.12 1.09 1.11 1.06
Support 2 (S2) 1.07 1.10 1.07 1.06
Support 3 (S3) 1.04 1.07 1.05
Support 4 (S4) 1.04